Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16721051rdf:typepubmed:Citationlld:pubmed
pubmed-article:16721051lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:16721051lifeskim:mentionsumls-concept:C2752147lld:lifeskim
pubmed-article:16721051lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:16721051lifeskim:mentionsumls-concept:C1421540lld:lifeskim
pubmed-article:16721051lifeskim:mentionsumls-concept:C1523116lld:lifeskim
pubmed-article:16721051lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:16721051pubmed:issue10lld:pubmed
pubmed-article:16721051pubmed:dateCreated2006-6-8lld:pubmed
pubmed-article:16721051pubmed:abstractTextGenetic pathologies involving deficits in DNA repair, like xeroderma pigmentosum (XP), show recurrent cell death, tissue degeneration and oncogenesis due to high sensitivity to ultraviolet radiation (UV). Various inducers including UV activate NF-kappaB, a pathway largely involved in cell proliferation and apoptosis. However, the mechanism(s) involving NF-kappaB activation by UV are poorly understood. To improve this knowledge, we examined NF-kappaB in two XP cell groups (XPC and XPD/TTD). XPC/D primary fibroblasts possess functional NF-kappaB dimers, and pro-inflammatory cytokines consistently activate NF-kappaB pathway. Contrarily, UV-mediated NF-kappaB activation is practically absent, whereas kappaB-specific DNA binding and transcriptional activity are dramatically undermined. These results indicate that lack of UV responsiveness at the NF-kappaB level is a common feature of XPC/D cells, suggesting that XP proteins might act upstream on NF-kappaB activity induced by UV. These observations help us to better understand the UV sensitivity and compromised survival of XP deficient cells.lld:pubmed
pubmed-article:16721051pubmed:languageenglld:pubmed
pubmed-article:16721051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:citationSubsetIMlld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16721051pubmed:statusMEDLINElld:pubmed
pubmed-article:16721051pubmed:monthMaylld:pubmed
pubmed-article:16721051pubmed:issn1551-4005lld:pubmed
pubmed-article:16721051pubmed:authorpubmed-author:BotteroVirgin...lld:pubmed
pubmed-article:16721051pubmed:authorpubmed-author:TergaonkarVin...lld:pubmed
pubmed-article:16721051pubmed:authorpubmed-author:MuotriAlysson...lld:pubmed
pubmed-article:16721051pubmed:authorpubmed-author:CorreaRicardo...lld:pubmed
pubmed-article:16721051pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16721051pubmed:volume5lld:pubmed
pubmed-article:16721051pubmed:ownerNLMlld:pubmed
pubmed-article:16721051pubmed:authorsCompleteYlld:pubmed
pubmed-article:16721051pubmed:pagination1085-9lld:pubmed
pubmed-article:16721051pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:meshHeadingpubmed-meshheading:16721051...lld:pubmed
pubmed-article:16721051pubmed:year2006lld:pubmed
pubmed-article:16721051pubmed:articleTitleUV-mediated NF-kappaB activation is abolished in deficient XPC/D primary fibroblasts.lld:pubmed
pubmed-article:16721051pubmed:affiliationThe Salk Institute for Biological Studies, La Jolla, California, USA.lld:pubmed
pubmed-article:16721051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16721051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16721051pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed